An observational case series of dabigatran and rivaroxaban exposures reported to a poison control system
- 1 September 2014
- journal article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 32 (9) , 1077-1084
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cerebral hemorrhage under rivaroxabanInternational Journal of Cardiology, 2013
- Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complicationsCritical Care, 2013
- Treatment of Bleeding Complications When Using Oral Anticoagulants for Prevention of StrokesCurrent Treatment Options in Cardiovascular Medicine, 2013
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With RivaroxabanStroke, 2013
- Extensive Postoperative Ecchymosis in a Patient Taking DabigatranJournal of Minimally Invasive Gynecology, 2013
- Determination of Rivaroxaban in Human Plasma SamplesSeminars in Thrombosis and Hemostasis, 2012
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor DabigatranStroke, 2011
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran EtexilateClinical Pharmacokinetics, 2010
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010
- Understanding the limitations of retrospective analyses of poison center dataClinical Toxicology, 2007